The main purpose of the seminar is to provide information regarding pharmaceutical manufacturing processes, packaging and address new regulatory requirements recently released by the FDA called the new Annex 1 which may shape the future of manufacturing. Producing solid dosage forms and injectables under OEB3 to OEB5 environments will be also covered. We will focus on sterile and solid dosage production with tabletop walks between presentations.